secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0001683168-23-000078
Event type: other_material
Sentiment:  neutral
Materiality: 0.00
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals updates investor presentation; no material new disclosures
--------------------------------------------------------------------------------

- Presentation highlights stabilized hypochlorous acid products for dermatology, wound care, eye care, and other applications.
- Company reports distribution in 55 countries via direct sales and partners.
- No financial results, guidance, or material operational changes were announced.
- Contains forward-looking statements with usual risk factors.
- Filing is a routine Regulation FD disclosure of an updated corporate overview.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316823000078/0001683168-23-000078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316823000078/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-000078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer